– EDG-5506 treatment significantly lowered muscle damage biomarkers in adults with BMD – – BMD patients were more active during 2 months of dosing with EDG-5506 relative to activity measured in BMD patients in the Phase 1 study – – EDG-5506 was well tolerated with no serious adverse events observed; safety profile supported dose escalation … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pertussis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Pertussis- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Pertussis, historical and forecasted epidemiology as well as the Pertussis market trends in the United States, EU5 (Germany, Spain, Italy, France, and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bronchial Hyperreactivity – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Bronchial Hyperreactivity- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Bronchial Hyperreactivity, historical and forecasted epidemiology as well as the Bronchial Hyperreactivity market trends in the United States, EU5 (Germany, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bronchial Spasms – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Bronchial Spasms- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Bronchial Spasms, historical and forecasted epidemiology as well as the Bronchial Spasms market trends in the United States, EU5 (Germany, … [Read more…]

Oregon Health & Science University (OHSU) launched the War on Melanoma to eliminate melanoma as a cause of death FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a new collaboration with OHSU’s War on Melanoma™. The War on Melanoma is a multi-faceted … [Read more…]

Application based on Phase 3 TRANSFORM study in which Breyanzi outperformed the current standard of care with demonstrated statistically significant improvement in event-free survival and a well-established safety profile PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #Bcell—Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency (EMA) has validated its type II variation application for extension of … [Read more…]

RALEIGH, N.C.–(BUSINESS WIRE)–Phreesia is proud to announce that Hilary Hatch, PhD, the company’s Chief Clinical Officer, has been selected to participate in the National Quality Forum (NQF)’s 2022 Leadership Consortium. Dr. Hatch’s inclusion in this expert group underscores Phreesia’s commitment to improving patients’ healthcare experiences and outcomes by enabling them to become more active participants … [Read more…]

Offers flexibility in blood collection tube choice enabling cost-effective workflows in non-invasive prenatal testing Scalable and precise DNA size selection reduces no-call rates for improved patient outcomes MANCHESTER, England–(BUSINESS WIRE)–Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, announces today the launch of the LightBench® Detect, the latest addition to its Ranger® … [Read more…]

BOCA RATON, Fla.–(BUSINESS WIRE)–#AndrewQueen–Integrated Dermatology, one of the nation’s largest providers of dermatology services, has expanded its South Florida network by partnering with Kenneth A. Rosen, M.D. Dermatology in Miami. The practice, which includes offices in Kendall and Miami Lakes, offers patients general dermatological care and cosmetic procedures. Dr. Rosen is an experienced, board-certified dermatologist … [Read more…]

Dxcover® Infrared Platform enables high-speed, low-cost, and sensitive early detection of multiple cancers DUBLIN–(BUSINESS WIRE)–Dxcover Limited, a clinical stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the launch of the Dxcover® platform, a ground-breaking platform that transforms Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectroscopy to enable … [Read more…]